187 related articles for article (PubMed ID: 21482111)
1. Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia.
Liewluck T; Shen XM; Milone M; Engel AG
Neuromuscul Disord; 2011 Jun; 21(6):387-95. PubMed ID: 21482111
[TBL] [Abstract][Full Text] [Related]
2. Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.
Rodríguez Cruz PM; Sewry C; Beeson D; Jayawant S; Squier W; McWilliam R; Palace J
Neuromuscul Disord; 2014 Dec; 24(12):1103-10. PubMed ID: 25127990
[TBL] [Abstract][Full Text] [Related]
3. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
Engel AG; Lambert EH; Gomez MR
Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
[TBL] [Abstract][Full Text] [Related]
4. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.
Slater CR; Fawcett PR; Walls TJ; Lyons PR; Bailey SJ; Beeson D; Young C; Gardner-Medwin D
Brain; 2006 Aug; 129(Pt 8):2061-76. PubMed ID: 16870884
[TBL] [Abstract][Full Text] [Related]
5. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
Engel AG; Nagel A; Walls TJ; Harper CM; Waisburg HA
Muscle Nerve; 1993 Dec; 16(12):1284-92. PubMed ID: 8232383
[TBL] [Abstract][Full Text] [Related]
6. Trouble at the junction: When myopathy and myasthenia overlap.
Nicolau S; Kao JC; Liewluck T
Muscle Nerve; 2019 Dec; 60(6):648-657. PubMed ID: 31449669
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
8. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
Uchitel O; Engel AG; Walls TJ; Nagel A; Atassi MZ; Bril V
Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
[TBL] [Abstract][Full Text] [Related]
9. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
Yoshimura T; Motomura M; Tsujihata M
Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
[TBL] [Abstract][Full Text] [Related]
11. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
Engel AG; Uchitel OD; Walls TJ; Nagel A; Harper CM; Bodensteiner J
Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
[TBL] [Abstract][Full Text] [Related]
12. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
Banwell BL; Ohno K; Sieb JP; Engel AG
Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
[TBL] [Abstract][Full Text] [Related]
13. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
14. GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity.
Selcen D; Shen XM; Milone M; Brengman J; Ohno K; Deymeer F; Finkel R; Rowin J; Engel AG
Neurology; 2013 Jul; 81(4):370-8. PubMed ID: 23794683
[TBL] [Abstract][Full Text] [Related]
15. How myasthenia gravis alters the safety factor for neuromuscular transmission.
Ruff RL; Lennon VA
J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
[TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
[TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndromes in two kinships with end-plate acetylcholine receptor and utrophin deficiency.
Sieb JP; Dörfler P; Tzartos S; Wewer UM; Rüegg MA; Meyer D; Baumann I; Lindemuth R; Jakschik J; Ries F
Neurology; 1998 Jan; 50(1):54-61. PubMed ID: 9443457
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
19. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
Oda K; Lambert EH; Lennon VA; Palmer AC
Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
[TBL] [Abstract][Full Text] [Related]
20. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
